STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,854,505 | -74.1% | 1,485,915 | -30.2% | 0.03% | -74.0% |
Q2 2023 | $22,644,430 | +28.5% | 2,130,238 | +0.7% | 0.13% | +36.5% |
Q1 2023 | $17,621,415 | +72.2% | 2,115,416 | +90.8% | 0.10% | +57.4% |
Q4 2022 | $10,235,267 | +115.8% | 1,108,913 | +200.3% | 0.06% | +96.8% |
Q3 2022 | $4,742,000 | – | 369,327 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |